Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations

被引:2
|
作者
Remlinger, Jana [1 ,2 ,3 ]
Bagnoud, Maud [1 ,2 ]
Meli, Ivo [1 ,2 ]
Massy, Marine [1 ,2 ,3 ]
Linington, Christopher [4 ]
Chan, Andrew [1 ,2 ]
Bennett, Jeffrey L. [5 ]
Hoepner, Robert [1 ,2 ]
Enzmann, Volker [2 ,6 ]
Salmen, Anke [1 ,2 ,7 ,8 ]
机构
[1] Univ Bern, Dept Neurol, Inselspital, Bern Univ Hosp, CH-3010 Bern, Switzerland
[2] Univ Bern, Dept Biomed Res DBMR, CH-3010 Bern, Switzerland
[3] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3010 Bern, Switzerland
[4] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Scotland
[5] Univ Colorado, Dept Neurol & Ophthalmol, Programs Neurosci & Immunol, Anschutz Med Campus, Aurora, CO 80045 USA
[6] Bern Univ Hosp, Inselspital, Dept Ophthalmol, CH-3010 Bern, Switzerland
[7] Bern Univ Hosp, Dept Neurol, Inselspital, Freiburgstr, CH-3010 Bern, Switzerland
[8] Univ Bern, Freiburgstr, CH-3010 Bern, Switzerland
关键词
MOG antibody-associated disorder; Neuromyelitis optica spectrum disorder; MOG-IgG; AQP4-IgG; Experimental autoimmune encephalomyelitis; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CNS DISEASE; DEMYELINATION; COMPLEMENT; AQUAPORIN-4; CYTOTOXICITY; DETERMINES; CRITERIA; UTILITY; LESIONS;
D O I
10.1016/j.msard.2023.104892
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) or aquaporin 4 (AQP4-IgG) are associated with CNS inflammatory disorders. We directly compared MOG35-55-induced experimental autoimmune encephalomyelitis exacerbated by MOG- and AQP4-IgG (versus isotype IgG, Iso-IgG). Disease severity was highest after MOG-IgG application. MOG- and AQP4-IgG administration increased disease incidence compared to Iso-IgG. Inflammatory lesions appeared earlier and with distinct localizations after AQP4-IgG administration. AQP4 intensity was more reduced after AQP4- than MOG-IgG administration at acute disease phase. The described models are suitable for comparative analyses of pathological features associated with MOG- and AQP4-IgG and the investigation of therapeutic interventions.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
    Ringelstein, M.
    Metz, I.
    Ruprecht, K.
    Koch, A.
    Rappold, J.
    Ingwersen, J.
    Mathys, C.
    Jarius, S.
    Brueck, W.
    Hartung, H-P
    Paul, F.
    Aktas, O.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 882 - 888
  • [22] Longitudinal Spinal Cord Atrophy Patterns in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Neuromyelitis Optica Spectrum Disorder
    Amin, Moein
    Nakamura, Kunio
    Ontaneda, Daniel
    Kunchok, Amy
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 270 - 270
  • [23] MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature
    Ikeda, Azusa
    Watanabe, Yoshihiro
    Kaba, Hikari
    Kaneko, Kimihiko
    Takahashi, Toshiyuki
    Takeshita, Saoko
    BRAIN & DEVELOPMENT, 2019, 41 (04): : 367 - 372
  • [24] Discrimination of spinal cord sarcoidosis from neuromyelitis optica spectrum disorder or spondylotic myelopathy
    Kuroda, H.
    Takahashi, T.
    Sato, D.
    Takai, Y.
    Nishiyama, S.
    Misu, T.
    Nakashima, I.
    Fujihara, K.
    Aoki, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 113 - 113
  • [25] Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease
    Chuquisana, Omar
    Spatola, Marianna
    Dinoto, Alessandro
    Sepulveda, Maria
    Mariotto, Sara
    Tintore, Mar
    Montalban, Xavier
    Comabella, Manuel
    Lunemann, Jan D.
    BRAIN, 2024, 148 (02) : e4 - e7
  • [26] Long-term Efficacy and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease
    Barreras, P.
    Vasileiou, E.
    Filippatou, A.
    Fitzgerald, K.
    Levy, M.
    Mowry, E. M.
    Calabresi, P.
    Sotirchos, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 145 - 146
  • [27] Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
    Bonnan, M.
    Valentino, R.
    Olindo, S.
    Mehdaoui, H.
    Smadja, D.
    Cabre, P.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (04) : 487 - 492
  • [28] Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease
    Barreras, Paula
    Vasileiou, Eleni S.
    Filippatou, Angeliki G.
    Fitzgerald, Kathryn C.
    Levy, Michael
    Pardo, Carlos A.
    Newsome, Scott D.
    Mowry, Ellen M.
    Calabresi, Peter A.
    Sotirchos, Elias S.
    NEUROLOGY, 2022, 99 (22) : E2504 - E2516
  • [29] Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis
    Hua, Tiantian
    Fan, Houyou
    Duan, Yunyun
    Tian, Decai
    Chen, Zhenpeng
    Xu, Xiaolu
    Bai, Yutong
    Li, Yuna
    Zhang, Ningnannan
    Sun, Jie
    Li, Haiqing
    Li, Yuxin
    Li, Yongmei
    Zeng, Chun
    Han, Xuemei
    Zhou, Fuqing
    Huang, Muhua
    Xu, Siyao
    Jin, Ying
    Li, Hongfang
    Zhuo, Zhizheng
    Zhang, Xinghu
    Liu, Yaou
    JOURNAL OF NEUROLOGY, 2024, 271 (06) : 3595 - 3609
  • [30] Neuromyelitis Optica Spectrum Disorder: A Rare Cause of Spinal Cord and Optic Nerve Involvement
    Douedi, Steven
    Pilarz, Lauren
    Al Kallas, Hala
    Pannu, Viraaj S.
    Odak, Mihir
    Kozlik, Ann
    Elmedani, Sarah
    Elkherpitawy, Islam
    Campbell, Natasha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)